SHANGHAI SHYNDEC PHARMACEUTICAL HAIMEN CO LTD

Overview

SHANGHAI SHYNDEC PHARMACEUTICAL HAIMEN CO LTD is an active pharmaceutical ingredient (API) supplier with 10 active FDA Type II Drug Master Files, covering CHLOROPROCAINE HYDROCHLORIDE; DIMENHYDRINATE; DULOXETINE HYDROCHLORIDE; DYPHYLLINE; ETHIODIZED OIL; FLURBIPROFEN SODIUM.

API / Drug Master Files

SHANGHAI SHYNDEC PHARMACEUTICAL HAIMEN CO LTD holds 10 active (10 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• FLURBIPROFEN SODIUMActive2024-05-13
• CHLOROPROCAINE HYDROCHLORIDEActive2023-12-19
• UNITHIOLUMActive2023-03-06
• UNITHIOLActive2021-03-02
• DULOXETINE HYDROCHLORIDEActive2020-03-16
• DYPHYLLINEActive2020-03-16
• LINAGLIPTINActive2018-01-04
• DIMENHYDRINATEActive2017-02-06
• ETHIODIZED OILActive2015-04-27
• ZIDOVUDINEActive2013-06-10

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to SHANGHAI SHYNDEC PHARMACEUTICAL HAIMEN CO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.